This is a community-generated profile. If you would like to claim it, please .
Accuri Cytometers Funding
$32.7M
88 rounds
Accuri Cytometers is active in the following markets / industries: biotechnology. The company has secured funding across 8 rounds, totaling in an amount of $32.7M. Their most recent funding was raised on October 19, 2010.
Funding Rounds
U
$6000000D
$4000000C
$13000000U
$2000000B
$100000B
$5000000U
$1750000A
$805000Investors of Accuri Cytometers
Perry Diclemente
Designer, businessman and entrepreneur. Aircraft design consultant, real estate portfolio manager and regional aircraft distributor.
Developer / Analyst. Technical skills and deep background in private equity, growth capital and M&A. Grosvenor Capital, CreditSuisse, Deloitte. MBA, Michigan.
Life sciences VC and early-stage investor with focus and expertise in research tools and synthetic biology. Kauffman Fellow. Operational experience; startup utility player. McKinsey. PhD Genetics. BS Physics. Unafraid of category-defying opportunities.
Arboretum Ventures
Baird Capital
F-Prime
Bill Hyun
Investor/Founder Vitra Bio, Charisela Bio, Accuri Cytometers, True Materials, BioTrue, Immusoft, Symbiosys Biowares, Fibralign, Newbridge Media, SEQ, Cytobank